Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pulmonx Corp (NQ: LUNG ) 7.300 -0.010 (-0.14%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pulmonx Corp < Previous 1 2 3 4 Next > Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022 July 19, 2022 From Pulmonx Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 July 11, 2022 Upgrades Via Benzinga Recap: Pulmonx Q4 Earnings February 23, 2022 Pulmonx (NASDAQ:LUNG) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Pulmonx... Via Benzinga Earnings Scheduled For November 2, 2021 November 02, 2021 Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... Via Benzinga 92 Biggest Movers From Friday May 09, 2022 Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... Via Benzinga 55 Stocks Moving In Friday's Mid-Day Session May 06, 2022 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. Via Benzinga Pulmonx: Q1 Earnings Insights May 03, 2022 Pulmonx (NASDAQ:LUNG) reported its Q1 earnings results on Tuesday, May 3, 2022 at 05:05 PM. Here's what investors need to know about the announcement. Earnings Pulmonx missed estimated earnings by... Via Benzinga Where Pulmonx Stands With Analysts February 25, 2022 Within the last quarter, Pulmonx (NASDAQ:LUNG) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1... Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session February 24, 2022 Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0.... Via Benzinga Global Stocks, Futures Crash; Nasdaq In Bear Market, Oil Soars Above $105 On Russia Attack February 24, 2022 U.S. stock index futures crashed along with global markets on Thursday as Russia’s assault on Ukraine sent investors fleeing risky assets, while the tech-heavy Nasdaq was set to open in a bear market. Via Talk Markets The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company February 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... Via Benzinga Pulmonx Corporation (LUNG) Q3 2021 Earnings Call Transcript November 03, 2021 LUNG earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US November 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... Via Benzinga Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 December 08, 2021 Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... Via Benzinga Chief Financial Officer Of Pulmonx Makes $224.56 Thousand Sale September 22, 2021 Derrick Sung, Chief Financial Officer at Pulmonx (NASDAQ:LUNG), made a large insider sell on September 21, according to a new SEC filing. What Happened: A Form 4 filing from the U... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment September 21, 2021 From Pulmonx Corporation Via Business Wire The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga 3 Healthcare Stocks That Might Skyrocket When COVID Is Over September 07, 2021 Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over? Via The Motley Fool Exposures COVID-19 Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage for Severe COPD/Emphysema Treatment August 20, 2021 From Pulmonx Corporation Via Business Wire Return on Capital Employed Overview: Pulmonx August 20, 2021 After pulling data from Benzinga Pro it seems like during Q2, Pulmonx (NASDAQ:LUNG) brought in sales totaling $12.20 million. However, earnings decreased 0.58%, resulting in a... Via Benzinga Pulmonx Corporation (LUNG) Q2 2021 Earnings Call Transcript August 04, 2021 LUNG earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business August 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits of Zephyr Valve for Patients with Severe COPD/Emphysema July 27, 2021 From Pulmonx Corporation Via Business Wire Pulmonx Corporation (LUNG) Q1 2021 Earnings Call Transcript May 05, 2021 LUNG earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts May 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety Earnings Scheduled For May 4, 2021 May 04, 2021 Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.